Temple-backed biotech firm secures $60 million to research HIV cure
Excision BioTherapeutics believes the gene-editing tool CRISPR may hold the key to curing HIV, the virus that turns to AIDS. The company, founded by two Temple Health researchers,…
More from Philadelphia Metro
PHL 17 | Philadelphia
New rule could impact your next delayed or canceled flight
Philadelphia Metro
•
1h ago
Philly Voice
Shop antiques, vinyl records and vintage finds at this year-round market in Wayne
Philadelphia Metro
•
2h ago
Villanova Wildcats
All Nine Wildcat Golfers Set to Play the Blue Hen Intercollegiate
Philadelphia Metro
•
4h ago
Philly Voice
Can social media bans protect young people's mental health? Early research suggests they aren't the answer
Philadelphia Metro
•
7h ago
WPVI ABC Sports
Week 7's best game? Impossible to choose on a wild Saturday
Philadelphia Metro
•
9h ago
